How Is Morocco Reacting to COVID-19 Crisis in AnticancerCenters?

摘要

The world is facing the pandemic linked to COVID-19 virus infection that has rapidlyspread worldwide, and severe complications have been reported to occur in around a thirdof patients. To date, there is no approved vaccine or specific therapy against COVID-19,but many trials are ongoing with some of them showing promising results. It has been shownrecently that patients with cancer are at high risk of infection and they are moresusceptible to develop severe events such as the necessity of invasive ventilation anddeath. Therefore, this crisis presents a real challenge for health systems especially inlow- and middle-income countries where the health systems are already fragile such asAfrican countries. In this article, we describe the epidemiological situation of theinfection in Morocco and the different challenges in cancer centers in the era ofCOVID-19, in addition to various strategies that have been implemented to prevent andcontrol the infection spread in oncological units in order to ensure the continuation ofadequate cancer care.